{
    "Trade/Device Name(s)": [
        "LZI Multiple Analyte Set A Drugs of Abuse Calibrators",
        "LZI Multiple Analyte Set A Drugs of Abuse Controls",
        "LZI Multiple Analyte Set B Drugs of Abuse Calibrators",
        "LZI Multiple Analyte Set B Drugs of Abuse Controls",
        "LZI Multiple Analyte Set C Drugs of Abuse Calibrators",
        "LZI Multiple Analyte Set C Drugs of Abuse Controls",
        "Lin-Zhi Multiple Analyte Set A, B and C Urine Drugs of Abuse Calibrators",
        "Lin-Zhi Multiple Analyte Set A, B and C Urine Drugs of Abuse Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K133710",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051088"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "December 2, 2013",
    "Summary Letter Received Date": "December 4, 2013",
    "Submission Date": "February 21, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology calibrator",
        "Drug Mixture Control Materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzoylecgonine",
        "Methamphetamine",
        "Methadone",
        "6-acetylmorphine",
        "MDMA",
        "Morphine",
        "Oxazepam",
        "Secobarbital"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Lin-Zhi Multiple Analyte Set A, B, and C Urine Drugs of Abuse Calibrators and Controls for toxicology assay calibration and validation.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as calibrators and controls for prescription use with homogeneous enzyme immunoassays on automated clinical chemistry analyzers for the listed drugs of abuse in human urine.",
    "fda_folder": "Toxicology"
}